ADHD medications do not significantly increase cardiovascular disease riskJanuary 16th 2023
A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.
Prenatal benzodiazepine exposure not directly associated with ASD and ADHDJanuary 11th 2023
A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.
AAP: How physicians can recognize and support victims of child exploitationDecember 23rd 2022
The American Academy of Pediatrics has updated their report, “Exploitation, Labor and Sex Trafficking of Children and Adolescents: Health Care Needs of Patients,” to provide updated guidance on how physicians can recognize and help children and adolescents subjected to trafficking or exploitation.
National hospital poll surveys parents beliefs on religious participation from teenagersDecember 21st 2022
In a recent Mott Poll, parents discussed their beliefs on how children aged 13 to 18 years benefit from religious services, how often these children should participate, and the level of freedom they would give their children to choose whether to participate.
Arcutis submits roflumilast cream for treating plaque psoriasis in patients aged 2 to 11 yearsDecember 19th 2022
Arcutis Biotherapeutics, Inc has submitted a supplemental New Drug Application for roflumilast cream (ZORYVE) to the US Food and Drug Administration for treatment of plaque psoriasis in children aged 2 to 11 years.